Great timing and find as far as I', concerned 7up - I may have missed this if it was posted before - thanks.
Hey Imrich, would you please do me a favor? Go to the link on 7up's post 37098 and look at the FDA release and attachments.
Whelan writes a letter, dated April 2 2014, in which he requests a shift from Rx to Class II for OTC, I presume for Recovery RX.
His letter also discusses ActiPatch in a couple of places. All this is labeled as a supplement. Note: "Supplement submitted to FDA" and "Supplement from BioElectronics Corporation" Is there a possibility that this is in fact a supplemental application, or request, sort of, to the current approved status of Recovery Rx asking that it be immediately re-positioned, re-identified, or re-whatever as Class II? Supplement as a stand alone word needs a little Viagra; Supplement to what? It appears to me to be the previous approval of RecoveryRx.
And, further the references to ActiPatch are interesting. Is RecoveryRx actually ActiPatch in every way? The names simply merchandising or Brand or use identity names?
Seems to me Whelan would never do this without having received very solid advice, even "direction" from legal or scientific counsel, or 'elsewhere', to submit it as a possible effective way through the maze, as it were . . . . .
I would very much appreciate your cautious thoughts and from any other good guys as well. Thanks.
